Datadog (DDOG)

Analysts remain constructive, with 44 of 48 rating it buy or strong buy and a median 12-month target of $275.00, yet CleaRank's own rating is Hold at 45/100 because the trend is down and the valuation is stretched. Investors are weighing strong revenue growth against a share price that has lost ground on every major average.

Datadog has lost ground over the past month, down 35.82%, and the 14-day RSI of 31.5 sits in the bearish zone, not yet oversold. The MACD line is negative, which points to momentum that is still weighed toward sellers. The price is 24.63% below its 50-day simple moving average of $244.64 and 8.21% below its 200-day average of $200.86. Those two averages are still in an uptrend relative to each other, with the 50-day sitting 8.21% below the 200-day, but the price has fallen beneath both. The 20-day exponential average of $222.45 is 20.65% above the price, which shows how far the recent decline has run. The one-year return of down 6.81% and six-month return of down 10.19% show a stock that has given back much of its earlier gains.

The business itself is growing quickly. Revenue rose 35.20% in the latest quarter compared with the same quarter a year earlier, which is 11.0 percentage points faster than the sector median of 24.2%. Net profit margin is 6.12% and operating margin is 6.33%, and debt-to-equity is 0.28, so the balance sheet is not the concern. Return on equity of 6.43% is below the sector median of 13.4%, which means the growth has not yet produced strong returns for shareholders. The valuation is the harder part of the story. The trailing P/E of 256.08 is at a premium to peers, with the sector median at 35.1, and the price-to-sales ratio of 15.56 is 104.7% above the sector median of 7.6. GAAP earnings per share over the last 12 months are $0.72, so the multiple rests on thin reported profit.

On November 5, 2026, Citigroup, TD Cowen, Scotiabank, Rosenblatt, DA Davidson and Macquarie all kept their ratings, so the Wall Street view did not change that day. Of 48 analysts with a current rating, 44 rate the stock buy or strong buy, 3 hold it and 1 sells it. Three months ago, 42 of 47 ratings were buy, so the share of buy ratings has risen slightly. Insiders, by contrast, sold $1.2B of stock across 183 sales over the last 18 months, and none bought on the open market. The general context is that insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market purchases would be.

The base case is that the stock stays range-bound and volatile while it works back toward its moving averages. For the trend to improve, the price needs to reclaim the 200-day average and then the 20-day average, and revenue growth needs to hold near its recent pace. The analysts' median target of $275.00 sits 49.1% above the price, and the highest target is $330.00, so the gap between Wall Street and the market is wide. The bear case is that the price loses the 52-week low of $98.01 region, or that growth slows toward the sector median of 24.2% while valuation stays at a large premium. The stock's typical daily move of 5.06% and beta of 1.51 mean that sharp swings in either direction are normal for this name. These are conditions to watch, not a forecast.

Support sits at the 52-week low of $98.01, the last level a fall would meet below the price, and that is a long way down. Resistance is nearest at the 200-day simple moving average of $200.86, which the price needs to clear first. Above it, the 20-day exponential moving average of $222.45 is the next test, followed by the 50-day simple moving average of $244.64. The 52-week high of $300.68 is the furthest mark above the price.